Cargando…

Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients

BACKGROUND: Ghrelin (GHRL) is a pivotal peptide regulator of food intake, energy balance, and body mass. Weight gain (WG) is a common side effect of the atypical antipsychotics (AAPs) used to treat schizophrenia (SZ). Ghrelin polymorphisms have been associated with pathogenic variations in plasma li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yongfeng, Li, Wenqiang, Zhao, Jingyuan, Zhang, Hongxing, Song, Xueqin, Xiao, Bo, Yang, Ge, Jiang, Chengdi, Zhang, Dai, Yue, Weihua, Lv, Luxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328252/ https://www.ncbi.nlm.nih.gov/pubmed/22369141 http://dx.doi.org/10.1186/1744-9081-8-11

Ejemplares similares

Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population
por: Guo, Weiyun, et al.
Publicado: (2017)

Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population
por: Yang, Yongfeng, et al.
Publicado: (2015)

Association of estrogen receptor alpha gene polymorphism with age at onset, general psychopathology symptoms, and therapeutic effect of schizophrenia
por: Wang, Shuai, et al.
Publicado: (2013)

Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
por: Dantas, Vitor G.L., et al.
Publicado: (2011)

Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population
por: Yang, Yongfeng, et al.
Publicado: (2018)

A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population
por: Yue, Weihua, et al.
Publicado: (2011)

The nuclear factor-κB inhibitor pyrrolidine dithiocarbamate reduces polyinosinic-polycytidilic acid-induced immune response in pregnant rats and the behavioral defects of their adult offspring
por: Song, Xueqin, et al.
Publicado: (2011)

Association of DTNBP1 With Schizophrenia: Findings From Two Independent Samples of Han Chinese Population
por: Yang, Yongfeng, et al.
Publicado: (2020)

ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study
por: Lu, Zhe, et al.
Publicado: (2022)

Abnormal functional connectivity of the striatum in first‐episode drug‐naive early‐onset Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2022)

Weak Association Between the Glutamate Decarboxylase 1 Gene (GAD1) and Schizophrenia in Han Chinese Population
por: Zhang, Luwen, et al.
Publicado: (2021)

Solute Carrier Family 1 (SLC1A1) Contributes to Susceptibility and Psychopathology Symptoms of Schizophrenia in the Han Chinese Population
por: Li, Wenqiang, et al.
Publicado: (2020)

Protocol for a pharmacogenomic study on individualised antipsychotic drug treatment for patients with schizophrenia
por: Su, Yi, et al.
Publicado: (2021)

Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2021)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Association of SYNE1 locus with bipolar disorder in Chinese population
por: Li, Wenqiang, et al.
Publicado: (2019)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder
por: Yang, Yongfeng, et al.
Publicado: (2019)

Dual Effect of the GHRL Gene Variant in the Molecular Pathogenesis of Obesity
por: Becer, E, et al.
Publicado: (2021)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Leu72Met and Other Intronic Polymorphisms in the GHRL and GHSR Genes Are Not Associated with Type 2 Diabetes Mellitus, Insulin Resistance, or Serum Ghrelin Levels in a Saudi Population
por: Joatar, Faris Elbahi, et al.
Publicado: (2017)

Genetic association and meta-analysis of a schizophrenia GWAS variant rs10489202 in East Asian populations
por: Yang, Yongfeng, et al.
Publicado: (2018)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
por: Sentissi, Othman, et al.
Publicado: (2008)

Severity in schizophrenia patients receiving atypical antipsychotic medications
por: Alam Fatmi1j, Syed Meraj, et al.
Publicado: (2022)

Genome wide association study identifies four loci for early onset schizophrenia
por: Guo, Suqin, et al.
Publicado: (2021)

GHRL Gene Leu72Met Polymorphism and Type 2 Diabetes Mellitus: A Meta-Analysis Involving 8,194 Participants
por: Li, Yan-yan, et al.
Publicado: (2019)

Reduced Gray Matter Volume in Orbitofrontal Cortex Across Schizophrenia, Major Depressive Disorder, and Bipolar Disorder: A Comparative Imaging Study
por: Yang, Yongfeng, et al.
Publicado: (2022)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2006)

Association of Typical versus Atypical Antipsychotics with Symptoms and Quality of Life in Schizophrenia
por: Fujimaki, Koichiro, et al.
Publicado: (2012)

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)

Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
por: Khasawneh, Fadi T., et al.
Publicado: (2014)

A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
por: Gilca, Marilena, et al.
Publicado: (2014)

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia
por: MacEwan, Joanna P., et al.
Publicado: (2016)

Decreased Functional Connectivity of Insular Cortex in Drug Naïve First Episode Schizophrenia: In Relation to Symptom Severity
por: Pang, Lijuan, et al.
Publicado: (2017)

Abnormal patterns of regional homogeneity and functional connectivity across the adolescent first-episode, adult first-episode and adult chronic schizophrenia
por: Yang, Yongfeng, et al.
Publicado: (2022)

Cortical anatomical variations, gene expression profiles, and clinical phenotypes in patients with schizophrenia
por: Han, Yong, et al.
Publicado: (2023)

GHRL as a prognostic biomarker correlated with immune infiltrates and progression of precancerous lesions in gastric cancer
por: Wang, Jinyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o3lieau83n3v7atsicong1ha79